Astellas Pharma Inc. and XenoPort, Inc. Announce the Launch of Regnite?? Tablets for Restless Legs Syndrome in Japan

TOKYO & SANTA CLARA, Calif.--(BUSINESS WIRE)--Astellas Pharma Inc. (Tokyo: 4503) and XenoPort, Inc. (NASDAQ: XNPT) announced today that Regnite (gabapentin enacarbil) Extended-Release Tablets will…
Read the full story: BioSpace.com Featured News